Back to trial detailsIntake questionnaire
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Applying to University of Kansas Hospital-Indian Creek Campus · Overland Park, Kansas
Answer a few short questions to share with the research team.
0 of 3 answered